Christopher Michael Doane

Title: Christopher Michael Doane: Innovator in Antibody Research

Introduction

Christopher Michael Doane is a notable inventor based in New Albany, IN (US). He has made significant contributions to the field of immunology, particularly in the development of antibodies against the West Nile Virus. With a total of 2 patents, his work is pivotal in advancing therapeutic and diagnostic methods for viral infections.

Latest Patents

Doane's latest patents focus on antibodies that specifically bind to antigens of the West Nile Virus (WNV). The inventions relate to compositions comprising these antibodies or fragments that can prevent, treat, or ameliorate symptoms associated with WNV infection. The methods involve administering an effective amount of these antibodies to human subjects, which can significantly impact the management of WNV infections. Additionally, his patents include diagnostic compositions that aid in detecting or diagnosing WNV infections.

Career Highlights

Christopher Michael Doane is affiliated with Washington University, where he continues to engage in groundbreaking research. His work has not only contributed to scientific knowledge but also holds potential for real-world applications in public health.

Collaborations

Doane has collaborated with esteemed colleagues such as Michael S. Diamond and Theodore Oliphant. These partnerships enhance the research efforts and broaden the impact of their findings in the field of virology.

Conclusion

Christopher Michael Doane's innovative work in antibody research against the West Nile Virus exemplifies the importance of scientific inquiry in addressing public health challenges. His contributions are vital for the development of effective treatments and diagnostic tools.